A randomized controlled trial of CBT therapy for adults with ADHD with and without medication.

PubWeight™: 0.89‹?›

🔗 View Article (PMC 3414742)

Published in BMC Psychiatry on April 05, 2012

Authors

Margaret Weiss1, Candice Murray, Michael Wasdell, Brian Greenfield, Lauren Giles, Lily Hechtman

Author Affiliations

1: University of British Columbia, Faculty of Medicine, 1488 Gordon Ave, West Vancouver, BC V7T 1R6, Canada. Margaret.weiss@me.com

Associated clinical trials:

Strength-based Treatment Approach for Adults With ADHD | NCT04832737

Articles cited by this

A 14-month randomized clinical trial of treatment strategies for attention-deficit/hyperactivity disorder. The MTA Cooperative Group. Multimodal Treatment Study of Children with ADHD. Arch Gen Psychiatry (1999) 13.56

The prevalence and correlates of adult ADHD in the United States: results from the National Comorbidity Survey Replication. Am J Psychiatry (2006) 11.85

Clinical relevance of the primary findings of the MTA: success rates based on severity of ADHD and ODD symptoms at the end of treatment. J Am Acad Child Adolesc Psychiatry (2001) 3.87

Efficacy of meta-cognitive therapy for adult ADHD. Am J Psychiatry (2010) 2.49

Meta-analysis of the efficacy of methylphenidate for treating adult attention-deficit/hyperactivity disorder. J Clin Psychopharmacol (2004) 2.36

Cognitive behavioral therapy vs relaxation with educational support for medication-treated adults with ADHD and persistent symptoms: a randomized controlled trial. JAMA (2010) 2.30

Cognitive-behavioral therapy for ADHD in medication-treated adults with continued symptoms. Behav Res Ther (2005) 2.08

ADHD Rating Scale IV: psychometric properties from a multinational study as a clinician-administered instrument. Int J Methods Psychiatr Res (2005) 1.49

A cognitive remediation programme for adults with Attention Deficit Hyperactivity Disorder. Aust N Z J Psychiatry (2002) 1.43

Psychotherapy of attention deficit hyperactivity disorder in adults--a pilot study using a structured skills training program. Eur Arch Psychiatry Clin Neurosci (2002) 1.42

Unrecognized attention-deficit hyperactivity disorder in adults presenting for outpatient psychotherapy. J Child Adolesc Psychopharmacol (1992) 1.37

Multimodal treatment of ADHD in the MTA: an alternative outcome analysis. J Am Acad Child Adolesc Psychiatry (2001) 1.25

Age-dependent expression of attention-deficit/hyperactivity disorder symptoms. Psychiatr Clin North Am (2004) 1.23

Cognitive behaviour therapy in medication-treated adults with ADHD and persistent symptoms: a randomized controlled trial. BMC Psychiatry (2011) 1.19

A combined treatment approach for adults with ADHD--results of an open study of 43 patients. J Atten Disord (2006) 1.15

Evaluation of group cognitive behavioral therapy for adults with ADHD. J Atten Disord (2008) 0.97

A randomized double-blind trial of paroxetine and/or dextroamphetamine and problem-focused therapy for attention-deficit/hyperactivity disorder in adults. J Clin Psychiatry (2006) 0.96

Therapy-relevant factors in adult ADHD from a cognitive behavioural perspective. Atten Defic Hyperact Disord (2010) 0.83

Evaluation of the efficacy and effectiveness of a structured disorder tailored psychotherapy in ADHD in adults: study protocol of a randomized controlled multicentre trial. Atten Defic Hyperact Disord (2010) 0.83

Articles by these authors

The MTA at 8 years: prospective follow-up of children treated for combined-type ADHD in a multisite study. J Am Acad Child Adolesc Psychiatry (2009) 6.71

3-year follow-up of the NIMH MTA study. J Am Acad Child Adolesc Psychiatry (2007) 3.33

Adolescent substance use in the multimodal treatment study of attention-deficit/hyperactivity disorder (ADHD) (MTA) as a function of childhood ADHD, random assignment to childhood treatments, and subsequent medication. J Am Acad Child Adolesc Psychiatry (2013) 2.30

Symptomatic improvement in children with ADHD treated with long-term methylphenidate and multimodal psychosocial treatment. J Am Acad Child Adolesc Psychiatry (2004) 2.16

Medication adherence in the MTA: saliva methylphenidate samples versus parent report and mediating effect of concomitant behavioral treatment. J Am Acad Child Adolesc Psychiatry (2009) 2.13

Effects of stimulant medication on growth rates across 3 years in the MTA follow-up. J Am Acad Child Adolesc Psychiatry (2007) 2.03

Which treatment for whom for ADHD? Moderators of treatment response in the MTA. J Consult Clin Psychol (2003) 2.02

Delinquent behavior and emerging substance use in the MTA at 36 months: prevalence, course, and treatment effects. J Am Acad Child Adolesc Psychiatry (2007) 1.98

Academic achievement and emotional status of children with ADHD treated with long-term methylphenidate and multimodal psychosocial treatment. J Am Acad Child Adolesc Psychiatry (2004) 1.88

Reaction time distribution analysis of neuropsychological performance in an ADHD sample. Child Neuropsychol (2006) 1.73

The services for children and adolescents-parent interview: development and performance characteristics. J Am Acad Child Adolesc Psychiatry (2004) 1.64

Long-term use of stimulants in children with attention deficit hyperactivity disorder: safety, efficacy, and long-term outcome. Paediatr Drugs (2003) 1.56

Secondary evaluations of MTA 36-month outcomes: propensity score and growth mixture model analyses. J Am Acad Child Adolesc Psychiatry (2007) 1.48

Assessment and management of attention-deficit hyperactivity disorder in adults. CMAJ (2003) 1.47

Effects of ethnicity on treatment attendance, stimulant response/dose, and 14-month outcome in ADHD. J Consult Clin Psychol (2003) 1.46

Observed classroom behavior of children with ADHD: relationship to gender and comorbidity. J Abnorm Child Psychol (2002) 1.45

Self-perceptions of competence in children with ADHD and comparison children. J Consult Clin Psychol (2004) 1.43

Peer-assessed outcomes in the multimodal treatment study of children with attention deficit hyperactivity disorder. J Clin Child Adolesc Psychol (2005) 1.41

Assessing medication effects in the MTA study using neuropsychological outcomes. J Child Psychol Psychiatry (2006) 1.34

Parent-reported homework problems in the MTA study: evidence for sustained improvement with behavioral treatment. J Clin Child Adolesc Psychol (2010) 1.31

Evidence, interpretation, and qualification from multiple reports of long-term outcomes in the Multimodal Treatment study of Children With ADHD (MTA): part I: executive summary. J Atten Disord (2008) 1.27

Cost-effectiveness of ADHD treatments: findings from the multimodal treatment study of children with ADHD. Am J Psychiatry (2005) 1.26

Socioeconomic status as a moderator of ADHD treatment outcomes. J Am Acad Child Adolesc Psychiatry (2002) 1.23

Social functioning in children with ADHD treated with long-term methylphenidate and multimodal psychosocial treatment. J Am Acad Child Adolesc Psychiatry (2004) 1.22

Patterns and predictors of adolescent academic achievement and performance in a sample of children with attention-deficit/hyperactivity disorder. J Clin Child Adolesc Psychol (2011) 1.20

Blood pressure and heart rate over 10 years in the multimodal treatment study of children with ADHD. Am J Psychiatry (2012) 1.18

Evidence, interpretation, and qualification from multiple reports of long-term outcomes in the Multimodal Treatment Study of children with ADHD (MTA): Part II: supporting details. J Atten Disord (2008) 1.18

Response to methylphenidate in children with attention deficit hyperactivity disorder and manic symptoms in the multimodal treatment study of children with attention deficit hyperactivity disorder titration trial. J Child Adolesc Psychopharmacol (2003) 1.15

Responsiveness in interactions of mothers and sons with ADHD: relations to maternal and child characteristics. J Abnorm Child Psychol (2002) 1.13

Peer rejection and friendships in children with Attention-Deficit/Hyperactivity Disorder: contributions to long-term outcomes. J Abnorm Child Psychol (2012) 1.13

A rapid-response outpatient model for reducing hospitalization rates among suicidal adolescents. Psychiatr Serv (2002) 1.12

Neuroimaging in attention-deficit hyperactivity disorder: beyond the frontostriatal circuitry. Can J Psychiatry (2009) 1.10

Incremental validity in the psychological assessment of children and adolescents. Psychol Assess (2003) 1.10

Time-dependent changes in positively biased self-perceptions of children with attention-deficit/hyperactivity disorder: a developmental psychopathology perspective. Dev Psychopathol (2010) 1.08

Developmental course of attention deficit hyperactivity disorder and its predictors. J Can Acad Child Adolesc Psychiatry (2013) 1.05

Efficacy of a novel biphasic controlled-release methylphenidate formula in adults with attention-deficit/hyperactivity disorder: results of a double-blind, placebo-controlled crossover study. J Clin Psychiatry (2007) 1.04

Construct validity of the adolescent borderline personality disorder: a review. Can Child Adolesc Psychiatr Rev (2004) 1.04

Nine months of multicomponent behavioral treatment for ADHD and effectiveness of MTA fading procedures. J Abnorm Child Psychol (2004) 1.03

Comorbidity in adults with attention-deficit hyperactivity disorder. Can J Psychiatry (2009) 1.03

Developmental processes in peer problems of children with attention-deficit/hyperactivity disorder in the Multimodal Treatment Study of Children With ADHD: developmental cascades and vicious cycles. Dev Psychopathol (2010) 1.00

A naturalistic study of predictors and risks of atypical antipsychotic use in an attention-deficit/hyperactivity disorder clinic. J Child Adolesc Psychopharmacol (2009) 1.00

Research forum on psychological treatment of adults with ADHD. J Atten Disord (2008) 0.99

Neuroimaging and genetics of borderline personality disorder: a review. J Psychiatry Neurosci (2007) 0.99

Looking beyond disfigurement: the experience of patients with head and neck cancer. J Palliat Care (2014) 0.97

The efficacy of 2 different dosages of methylphenidate in treating adults with attention-deficit hyperactivity disorder. Can J Psychiatry (2003) 0.97

Amfetamine and methylphenidate medications for attention-deficit/hyperactivity disorder: complementary treatment options. Eur Child Adolesc Psychiatry (2012) 0.97

Treatment-related changes in objectively measured parenting behaviors in the multimodal treatment study of children with attention-deficit/hyperactivity disorder. J Consult Clin Psychol (2006) 0.96

A clinical review of outcomes of the multimodal treatment study of children with attention-deficit/hyperactivity disorder (MTA). Curr Psychiatry Rep (2008) 0.96

Treatment for ADHD: is more complex treatment cost-effective for more complex cases? Health Serv Res (2007) 0.96

A randomized double-blind trial of paroxetine and/or dextroamphetamine and problem-focused therapy for attention-deficit/hyperactivity disorder in adults. J Clin Psychiatry (2006) 0.96

Parental Agreement on ADHD Symptom-Specific and Broadband Externalizing Ratings of Child Behavior. J Emot Behav Disord (2010) 0.95

The psychosocial functioning of children and spouses of adults with ADHD. J Child Psychol Psychiatry (2003) 0.93

Suicide attempts: prevention of repetition. Can J Psychiatry (2011) 0.92

Once-daily multilayer-release methylphenidate in a double-blind, crossover comparison to immediate-release methylphenidate in children with attention-deficit/hyperactivity disorder. J Child Adolesc Psychopharmacol (2007) 0.91

Treatment of adults with attention-deficit/hyperactivity disorder. Neuropsychiatr Dis Treat (2008) 0.90

Cognitive behavior therapy for adults with attention-deficit/hyperactivity disorder: a review of recent randomized controlled trials. Curr Psychiatry Rep (2012) 0.90

Relation between outcomes on a continuous performance test and ADHD symptoms over time. J Abnorm Child Psychol (2011) 0.88

Using long-acting stimulants: does it change ADHD treatment outcome? Can Child Adolesc Psychiatr Rev (2005) 0.87

Reliability and diagnostic efficiency of the abbreviated-diagnostic interview for borderlines in an adolescent clinical population. Eur Child Adolesc Psychiatry (2009) 0.87

Design and rationale of controlled study of long-term methylphenidate and multimodal psychosocial treatment in children with ADHD. J Am Acad Child Adolesc Psychiatry (2004) 0.85

Developmental progression to early adult binge drinking and marijuana use from worsening versus stable trajectories of adolescent attention deficit/hyperactivity disorder and delinquency. Addiction (2015) 0.83

Patterns of antidepressant use in Quebec children and adolescents: trends and predictors. Psychiatry Res (2010) 0.83

Continuous versus intermittent infusions of antibiotics for the treatment of severe acute infections. Cochrane Database Syst Rev (2013) 0.83

Bulimia nervosa symptoms in the multimodal treatment study of children with ADHD. Int J Eat Disord (2010) 0.82

Children with ADHD treated with long-term methylphenidate and multimodal psychosocial treatment: impact on parental practices. J Am Acad Child Adolesc Psychiatry (2004) 0.81

Focussing both eyes on health outcomes: revisiting cataract surgery. BMC Geriatr (2012) 0.80

Treatment refusal in adolescents with severe chronic illness and borderline personality disorder. J Can Acad Child Adolesc Psychiatry (2006) 0.80

A post hoc analysis of d-threo-methylphenidate hydrochloride (focalin) versus d,l-threo-methylphenidate hydrochloride (ritalin). J Am Acad Child Adolesc Psychiatry (2004) 0.80

Perceived social acceptance and peer status differentially predict adjustment in youth with and without ADHD. J Atten Disord (2012) 0.80

Does childhood positive self-perceptual bias mediate adolescent risky behavior in youth from the MTA study? J Consult Clin Psychol (2013) 0.79

Child and parent predictors of perceptions of parent--child relationship quality. J Atten Disord (2007) 0.79

The benefits of laparoscopic appendectomies in obese patients. Am J Surg (2012) 0.79

Carnitine for fatigue in multiple sclerosis. Cochrane Database Syst Rev (2012) 0.79

Prospective follow-up studies of ADHD: helping establish a valid diagnosis in adults. J Am Acad Child Adolesc Psychiatry (2011) 0.79

Treatment of adults with attention-deficit/hyperactivity disorder. Neuropsychiatr Dis Treat (2008) 0.78

Discriminating between children with ADHD and classmates using peer variables. J Atten Disord (2008) 0.78

The effects of instructions on mothers' ratings of attention-deficit/hyperactivity disorder symptoms in referred children. J Abnorm Child Psychol (2014) 0.78

Adults with attention-deficit/hyperactivity disorder: current concepts. J Psychiatr Pract (2002) 0.78

Emergency/Adjunct services and attrition prevention for randomized clinical trials in children: the MTA manual-based solution. J Am Acad Child Adolesc Psychiatry (2002) 0.77

Carnitine for fatigue in multiple sclerosis. Cochrane Database Syst Rev (2010) 0.77

Clinical correlates of oppositional defiant disorder and attention-deficit/hyperactivity disorder in adults. Postgrad Med (2011) 0.77

Comorbidity and neuroimaging in attention-deficit hyperactivity disorder. Can J Psychiatry (2009) 0.77

Current issues and trends in the diagnosis and treatment of adults with ADHD. Expert Rev Neurother (2007) 0.76

Introduction personality disorders in childhood and adolescence. Can Child Adolesc Psychiatr Rev (2004) 0.76

Effect of Research Questionnaires on Satisfaction with Treatment Care in Suicidal Adolescents and their Parents. J Can Acad Child Adolesc Psychiatry (2011) 0.75

Response to commentary on the multimodal treatment study of ADHD (MTA): mining the meaning of the MTA. J Abnorm Child Psychol (2002) 0.75

Pharmacological treatment of attention-deficit/hyperactivity disorder in adults. Expert Opin Investig Drugs (2006) 0.75

Response to the letter to the Editor. J Can Acad Child Adolesc Psychiatry (2006) 0.75

The effects of instructions on mothers' ratings of child attention-deficit/hyperactivity disorder symptoms. J Abnorm Child Psychol (2011) 0.75

Effectiveness of risk communication interventions on the medical follow-up of youth treated with antidepressants. Psychiatry Res (2013) 0.75

Sexual maturation among youth with ADHD and the impact of stimulant medication. Eur Child Adolesc Psychiatry (2014) 0.75